TaqMan real-time PCR assay for specific detection of Opisthorchis viverrini DNA in Thai patients with hepatocellular carcinoma and cholangiocarcinoma.

[1]  Banchob Sripa,et al.  Liver Fluke Induces Cholangiocarcinoma , 2007, PLoS medicine.

[2]  X. Qiang,et al.  Helicobacter infection in hepatocellular carcinoma tissue. , 2006, World journal of gastroenterology.

[3]  W. Al-Soud,et al.  Helicobacter pylori and other Helicobacter species in gallbladder and liver of patients with chronic cholecystitis detected by immunological and molecular methods , 2005, Scandinavian journal of gastroenterology.

[4]  P. Pisani,et al.  Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand , 2004, Tropical medicine & international health : TM & IH.

[5]  D. Queiroz,et al.  Association of the Presence of Helicobacter in Gallbladder Tissue with Cholelithiasis and Cholecystitis , 2003, Journal of Clinical Microbiology.

[6]  A. Giorgio,et al.  Helicobacter spp. and liver diseases. , 2003, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

[7]  F. Shanahan,et al.  Review article: colitis‐associated cancer – time for new strategies , 2003, Alimentary pharmacology & therapeutics.

[8]  P. Watanapa,et al.  Liver fluke‐associated cholangiocarcinoma , 2002, The British journal of surgery.

[9]  V. Yajnik,et al.  Pathology and genetics of tumors of the digestive system , 2001 .

[10]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[11]  R. Sermswan,et al.  Development of a PCR-based method for the detection of Opisthorchis viverrini in experimentally infected hamsters , 2001, Parasitology.

[12]  F. Mégraud,et al.  Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma , 2000, Cancer.

[13]  L. Silengo,et al.  Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? , 2000, Medical hypotheses.

[14]  H. El‐Serag,et al.  Rising Incidence of Hepatocellular Carcinoma in the United States , 1999, Infection Control & Hospital Epidemiology.

[15]  J. Misiewicz.  Helicobacter Infection , 1999 .

[16]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1997 .

[17]  A. Bhalla,et al.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. , 1997, Gastroenterology.

[18]  I. Pogribny,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995 .

[19]  K. Livak,et al.  Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. , 1995, PCR methods and applications.

[20]  G. Ramadori,et al.  [Current therapeutic strategies in hepatocellular carcinoma, Part 1]. , 1994, Leber, Magen, Darm.

[21]  Russell Higuchi,et al.  Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions , 1993, Bio/Technology.

[22]  S. Panyim,et al.  Isolation and characterization of Opisthorchis viverrini specific DNA probe. , 1991, Molecular and cellular probes.

[23]  D. Parkin,et al.  Liver cancer in Thailand. I. A case‐control study of cholangiocarcinoma , 1991, International journal of cancer.

[24]  D. Parkin,et al.  Liver cancer in Thailand: Temporal and geographic variations , 1988 .

[25]  N. Bhamarapravati,et al.  Liver diseases in Thailand. An analysis of liver biopsies. , 1966, The American journal of gastroenterology.

[26]  Thomas D. Schmittgen,et al.  Real-Time Quantitative PCR , 2002 .

[27]  U. Stenram,et al.  Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. , 2001, Gastroenterology.

[28]  V. Vatanasapt,et al.  Cancer in Thailand 1988-1991 , 1993 .